On November 12, 2009, Lanny A. Breuer, the Assistant Attorney General in charge of the Criminal Division for the United States Department of Justice (DOJ), gave the Keynote Address at the Tenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum. His message was loud and clear: DOJ enforcement of the Foreign Corrupt Practices Act (FCPA) is going to become even more aggressive, and the health care industry is the next target.